Table 2.
NC | Early MCI | MCI | Combined sample | p | |
---|---|---|---|---|---|
Sample size | 174 | 27 | 131 | 332 | — |
Demographic characteristics | |||||
Age, years | 72 ± 7 | 73 ± 6 | 73 ± 8 | 73 ± 7 | .66 |
Sex, % female | 41 | 26 | 44 | 41 | .24 |
Race, % White/non-Hispanic | 87 | 85 | 85 | 86 | .88 |
Education, years | 16 ± 3 | 16 ± 3 | 15 ± 3 | 16 ± 3 | <.001*,§,¶ |
Biber Figure Learning Test performances | |||||
Trial 1 | 14.4 ± 5.4 | 11.1 ± 5.2 | 8.6 ± 5.4 | 11.8 ± 6.1 | <.001*,‡,§,¶ |
Trial 2 | 24.4 ± 6.8 | 18.4 ± 7.1 | 14.2 ± 6.9 | 19.9 ± 8.4 | <.001*,‡,§,¶ |
Trial 3 | 29.4 ± 7.3 | 23.9 ± 6.9 | 17.9 ± 7.7 | 24.4 ± 9.2 | <.001*,‡,§,¶ |
Trial 4 | 32.5 ± 7.3 | 27.2 ± 6.2 | 19.8 ± 8.3 | 27.1 ± 9.7 | <.001*,‡,§,¶ |
Trial 5 | 34.5 ± 7.1 | 29.4 ± 5.9 | 21.8 ± 9.4 | 29.1 ± 10.0 | <.001*,‡,§,¶ |
Total Learning (Trials 1–5) | 135 ± 31 | 110 ± 28 | 82 ± 35 | 112 ± 41 | <.001*,‡,§,¶ |
Distractor Trial (Trial B) | 11.7 ± 5.8 | 8.9 ± 4.8 | 7.3 ± 4.8 | 9.7 ± 5.7 | <.001*,‡,§ |
Short Delay Free Recall | 31.2 ± 8.1 | 26.3 ± 6.2 | 17.6 ± 9.8 | 25.4 ± 10.8 | <.001*,‡,§,¶ |
Long Delay Free Recall | 32.5 ± 7.6 | 28.0 ± 6.6 | 19.1 ± 9.9 | 26.8 ± 10.6 | <.001*,‡,§,¶ |
Long Delay Recognition–Hits | 14.0 ± 1.5 | 13.2 ± 1.6 | 12.5 ± 2.4 | 13.4 ± 2.0 | <.001*,‡,§ |
Long Delay Recognition–Related False Alarms | 0.9 ± 1.3 | 1.2 ± 1.3 | 2.3 ± 1.6 | 1.5 ± 1.6 | <.001*,§,¶ |
Long Delay Recognition–Unrelated False Alarms | 1.2 ± 1.9 | 2.5 ± 2.7 | 4.5 ± 3.7 | 2.6 ± 3.2 | <.001*,‡,§,¶ |
Long Delay Recognition–Total False Alarms | 2.1 ± 2.8 | 3.7 ± 3.7 | 6.8 ± 4.9 | 4.1 ± 4.4 | <.001*,‡,§,¶ |
Long Delay Recognition–Discrimination | 0.8 ± 0.2 | 0.7 ± 0.2 | 0.6 ± 0.2 | 0.7 ± 0.2 | <.001*,‡,§,¶ |
Total Repetitions | 0.2 ± 0.5 | 0.2 ± 0.4 | 0.3 ± 0.8 | 0.2 ± 0.6 | .88 |
Total Intrusions | 0.6 ± 1.5 | 0.3 ± 0.5 | 0.7 ± 3.2 | 0.6 ± 2.3 | .18 |
Proactive Interference | −2.7 ± 5.7 | −2.2 ± 5.2 | −1.25 ± 4.8 | −2.1 ± 5.4 | .01*,§ |
Retroactive Interference | −3.3 ± 4.4 | −3.2 ± 2.5 | −4.2 ± 4.7 | −3.7 ± 4.4 | .32 |
Brain MRI measures | |||||
Right hippocampal volume, mm3 | 3875 ± 437 | 3741 ± 343 | 3613 ± 468 | 3759 ± 459 | <.001*,§ |
Left hippocampal volume, mm3 | 3537 ± 425 | 3348 ± 323 | 3243 ± 467 | 3404 ± 456 | <.001*,‡,§ |
Total hippocampal volume, mm3 | 7412 ± 840 | 7089 ± 629 | 6856 ± 878 | 7163 ± 879 | <.001*,§ |
Right inferior lateral ventricle volume, mm3 | 807 ± 439 | 964 ± 652 | 1147 ± 747 | 956 ± 617 | <.001*,§ |
Left inferior lateral ventricle volume, mm3 | 869 ± 471 | 1011 ± 615 | 1254 ± 836 | 1034 ± 675 | <.001* |
Total inferior lateral ventricle volume, mm3 | 1676 ± 879 | 1974 ± 1232 | 2401 ± 1493 | 1990 ± 1235 | <.001*,§ |
Intracranial volume, cm3 | 1377 ± 142 | 1406 ± 106 | 1380 ± 150 | 1381 ± 142 | .47 |
White matter hyperintensity volume (log-transformed) | 2.0 ± 1.0 | 2.2 ± 0.7 | 2.5 ± 1.0 | 2.2 ± 1.0 | <.001*,§ |
Cerebrospinal fluid markers | |||||
Amyloid-β42, pg/mL | 757 ± 230 | 817 ± 282 | 620 ± 234 | 713 ± 246 | .001*,§,¶ |
Total-tau, pg/mL | 373 ± 175 | 429 ± 125 | 505 ± 289 | 427 ± 228 | .011*,§ |
Phosphorylated-tau, pg/mL | 56 ± 22 | 63 ± 17 | 68 ± 31 | 61 ± 26 | .049*,§ |
Neurofilament light, pg/mL | 936 ± 453 | 1088 ± 465 | 1253 ± 718 | 1069 ± 583 | .003*,§ |
Note. NC = cognitively normal control; MCI = mild cognitive impairment. Data presented as mean ± standard deviation or frequencies.
p < .05.
NC > early MCI.
NC > MCI;
Early MCI > MCI.